Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis

OBJECTIVE:We investigated potential interactions between human leukocyte antigen (HLA) genotype and body mass index (BMI) status in relation to the risk of developing multiple sclerosis (MS). METHODS:We used 2 case-control studies, one with incident cases (1,510 cases, 2,017 controls) and one with p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2014-03, Vol.82 (10), p.865-872
Hauptverfasser: Hedström, Anna Karin, Lima Bomfim, Izaura, Barcellos, Lisa, Gianfrancesco, Milena, Schaefer, Catherine, Kockum, Ingrid, Olsson, Tomas, Alfredsson, Lars
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 872
container_issue 10
container_start_page 865
container_title Neurology
container_volume 82
creator Hedström, Anna Karin
Lima Bomfim, Izaura
Barcellos, Lisa
Gianfrancesco, Milena
Schaefer, Catherine
Kockum, Ingrid
Olsson, Tomas
Alfredsson, Lars
description OBJECTIVE:We investigated potential interactions between human leukocyte antigen (HLA) genotype and body mass index (BMI) status in relation to the risk of developing multiple sclerosis (MS). METHODS:We used 2 case-control studies, one with incident cases (1,510 cases, 2,017 controls) and one with prevalent cases (937 cases, 609 controls). Subjects with different genotypes and BMI were compared with regard to incidence of MS by calculating odds ratios (ORs) with 95% confidence intervals (CIs) employing logistic regression. Potential interactions between genotypes and BMI were evaluated by calculating the attributable proportion due to interaction. RESULTS:In both cohorts, a significant interaction was observed between HLA-DRB1*15 and obesity, regardless of HLA-A*02 status. Similarly, there was a significant interaction between absence of A*02 and obesity, regardless of DRB1*15 status. In the incident cohort, obese subjects with the most susceptible genotype (carriage of DRB1*15 and absence of A*02) had an OR of 16.2 (95% CI 7.5–35.2) compared to nonobese subjects without the genetic risk factors. The corresponding OR in the prevalent study was 13.8 (95% CI 4.1–46.8). CONCLUSIONS:We observed striking interactions between BMI status and HLA genotype with regard to MS risk. Hypothetically, a low-grade inflammatory response inherent to obesity synergizes with the adaptive, HLA molecule–restricted arm of the immune system, causing MS. Prevention of adolescent obesity may thus lower the risk of developing MS, predominantly among people with a genetic susceptibility to the disease.
doi_str_mv 10.1212/WNL.0000000000000203
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_523800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1635038235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5583-d3e03b877d0e8440833f87ecd1f9cc83e964040e2114103f48833a820c55de763</originalsourceid><addsrcrecordid>eNp9kk1vEzEQhi0EoiHwDxDyBYnLFn_uei9IVQVtpQguILhZjnc2MXHsYHuJ8u_rKqG0HPDF1szzjsfzGqHXlJxTRtn7758X5-ThYoQ_QTMqWdu0nP14imY1phquOnWGXuT8k5Ca7Prn6IwJSUgruhnSN6FAMra4GPASyh4gYDNED9lCKDguIbtywCYM-HpxgZPLG7yCABm7gMsaMFSpj6sDjiPeTr64nQecrYcUs8sv0bPR-AyvTvscffv08evldbP4cnVzebForJSKNwMHwpeq6wYCSgiiOB9VB3agY2-t4tC3gggCjFJBCR-FqoRRjFT5AF3L56g51s172E1LvUtua9JBR-P0KbSpJ9CScUVI5T8c-ZrZwnD31mT8I9njTHBrvYq_Ne9l39Uic_TuVCDFXxPkoreujsx7EyBOWdOWS8IV47Ki4ojaOpKcYLy_hhJ956WuXup_vayyNw9bvBf9Ma8Cb0-Aydb4MZlgXf7LKS7rZ1CVU0duH301O2_8tIek12B8Wf-_h1vzIrlM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1635038235</pqid></control><display><type>article</type><title>Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><source>Journals@Ovid Complete</source><creator>Hedström, Anna Karin ; Lima Bomfim, Izaura ; Barcellos, Lisa ; Gianfrancesco, Milena ; Schaefer, Catherine ; Kockum, Ingrid ; Olsson, Tomas ; Alfredsson, Lars</creator><creatorcontrib>Hedström, Anna Karin ; Lima Bomfim, Izaura ; Barcellos, Lisa ; Gianfrancesco, Milena ; Schaefer, Catherine ; Kockum, Ingrid ; Olsson, Tomas ; Alfredsson, Lars</creatorcontrib><description>OBJECTIVE:We investigated potential interactions between human leukocyte antigen (HLA) genotype and body mass index (BMI) status in relation to the risk of developing multiple sclerosis (MS). METHODS:We used 2 case-control studies, one with incident cases (1,510 cases, 2,017 controls) and one with prevalent cases (937 cases, 609 controls). Subjects with different genotypes and BMI were compared with regard to incidence of MS by calculating odds ratios (ORs) with 95% confidence intervals (CIs) employing logistic regression. Potential interactions between genotypes and BMI were evaluated by calculating the attributable proportion due to interaction. RESULTS:In both cohorts, a significant interaction was observed between HLA-DRB1*15 and obesity, regardless of HLA-A*02 status. Similarly, there was a significant interaction between absence of A*02 and obesity, regardless of DRB1*15 status. In the incident cohort, obese subjects with the most susceptible genotype (carriage of DRB1*15 and absence of A*02) had an OR of 16.2 (95% CI 7.5–35.2) compared to nonobese subjects without the genetic risk factors. The corresponding OR in the prevalent study was 13.8 (95% CI 4.1–46.8). CONCLUSIONS:We observed striking interactions between BMI status and HLA genotype with regard to MS risk. Hypothetically, a low-grade inflammatory response inherent to obesity synergizes with the adaptive, HLA molecule–restricted arm of the immune system, causing MS. Prevention of adolescent obesity may thus lower the risk of developing MS, predominantly among people with a genetic susceptibility to the disease.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000000203</identifier><identifier>PMID: 24500647</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: American Academy of Neurology</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Body Mass Index ; Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Genotype ; HLA-A2 Antigen - genetics ; HLA-DRB1 Chains - genetics ; Humans ; Immunomodulators ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Multiple Sclerosis - epidemiology ; Multiple Sclerosis - etiology ; Multiple Sclerosis - genetics ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Obesity ; Pediatric Obesity - epidemiology ; Pediatric Obesity - genetics ; Pharmacology. Drug treatments ; Risk Factors ; Young Adult</subject><ispartof>Neurology, 2014-03, Vol.82 (10), p.865-872</ispartof><rights>2014 American Academy of Neurology</rights><rights>2015 INIST-CNRS</rights><rights>2014 American Academy of Neurology 2014 American Academy of Neurology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5583-d3e03b877d0e8440833f87ecd1f9cc83e964040e2114103f48833a820c55de763</citedby><cites>FETCH-LOGICAL-c5583-d3e03b877d0e8440833f87ecd1f9cc83e964040e2114103f48833a820c55de763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28355268$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24500647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:129110717$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Hedström, Anna Karin</creatorcontrib><creatorcontrib>Lima Bomfim, Izaura</creatorcontrib><creatorcontrib>Barcellos, Lisa</creatorcontrib><creatorcontrib>Gianfrancesco, Milena</creatorcontrib><creatorcontrib>Schaefer, Catherine</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><title>Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis</title><title>Neurology</title><addtitle>Neurology</addtitle><description>OBJECTIVE:We investigated potential interactions between human leukocyte antigen (HLA) genotype and body mass index (BMI) status in relation to the risk of developing multiple sclerosis (MS). METHODS:We used 2 case-control studies, one with incident cases (1,510 cases, 2,017 controls) and one with prevalent cases (937 cases, 609 controls). Subjects with different genotypes and BMI were compared with regard to incidence of MS by calculating odds ratios (ORs) with 95% confidence intervals (CIs) employing logistic regression. Potential interactions between genotypes and BMI were evaluated by calculating the attributable proportion due to interaction. RESULTS:In both cohorts, a significant interaction was observed between HLA-DRB1*15 and obesity, regardless of HLA-A*02 status. Similarly, there was a significant interaction between absence of A*02 and obesity, regardless of DRB1*15 status. In the incident cohort, obese subjects with the most susceptible genotype (carriage of DRB1*15 and absence of A*02) had an OR of 16.2 (95% CI 7.5–35.2) compared to nonobese subjects without the genetic risk factors. The corresponding OR in the prevalent study was 13.8 (95% CI 4.1–46.8). CONCLUSIONS:We observed striking interactions between BMI status and HLA genotype with regard to MS risk. Hypothetically, a low-grade inflammatory response inherent to obesity synergizes with the adaptive, HLA molecule–restricted arm of the immune system, causing MS. Prevention of adolescent obesity may thus lower the risk of developing MS, predominantly among people with a genetic susceptibility to the disease.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>HLA-A2 Antigen - genetics</subject><subject>HLA-DRB1 Chains - genetics</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Multiple Sclerosis - epidemiology</subject><subject>Multiple Sclerosis - etiology</subject><subject>Multiple Sclerosis - genetics</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><subject>Obesity</subject><subject>Pediatric Obesity - epidemiology</subject><subject>Pediatric Obesity - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Risk Factors</subject><subject>Young Adult</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp9kk1vEzEQhi0EoiHwDxDyBYnLFn_uei9IVQVtpQguILhZjnc2MXHsYHuJ8u_rKqG0HPDF1szzjsfzGqHXlJxTRtn7758X5-ThYoQ_QTMqWdu0nP14imY1phquOnWGXuT8k5Ca7Prn6IwJSUgruhnSN6FAMra4GPASyh4gYDNED9lCKDguIbtywCYM-HpxgZPLG7yCABm7gMsaMFSpj6sDjiPeTr64nQecrYcUs8sv0bPR-AyvTvscffv08evldbP4cnVzebForJSKNwMHwpeq6wYCSgiiOB9VB3agY2-t4tC3gggCjFJBCR-FqoRRjFT5AF3L56g51s172E1LvUtua9JBR-P0KbSpJ9CScUVI5T8c-ZrZwnD31mT8I9njTHBrvYq_Ne9l39Uic_TuVCDFXxPkoreujsx7EyBOWdOWS8IV47Ki4ojaOpKcYLy_hhJ956WuXup_vayyNw9bvBf9Ma8Cb0-Aydb4MZlgXf7LKS7rZ1CVU0duH301O2_8tIek12B8Wf-_h1vzIrlM</recordid><startdate>20140311</startdate><enddate>20140311</enddate><creator>Hedström, Anna Karin</creator><creator>Lima Bomfim, Izaura</creator><creator>Barcellos, Lisa</creator><creator>Gianfrancesco, Milena</creator><creator>Schaefer, Catherine</creator><creator>Kockum, Ingrid</creator><creator>Olsson, Tomas</creator><creator>Alfredsson, Lars</creator><general>American Academy of Neurology</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20140311</creationdate><title>Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis</title><author>Hedström, Anna Karin ; Lima Bomfim, Izaura ; Barcellos, Lisa ; Gianfrancesco, Milena ; Schaefer, Catherine ; Kockum, Ingrid ; Olsson, Tomas ; Alfredsson, Lars</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5583-d3e03b877d0e8440833f87ecd1f9cc83e964040e2114103f48833a820c55de763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>HLA-A2 Antigen - genetics</topic><topic>HLA-DRB1 Chains - genetics</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Multiple Sclerosis - epidemiology</topic><topic>Multiple Sclerosis - etiology</topic><topic>Multiple Sclerosis - genetics</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><topic>Obesity</topic><topic>Pediatric Obesity - epidemiology</topic><topic>Pediatric Obesity - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Risk Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hedström, Anna Karin</creatorcontrib><creatorcontrib>Lima Bomfim, Izaura</creatorcontrib><creatorcontrib>Barcellos, Lisa</creatorcontrib><creatorcontrib>Gianfrancesco, Milena</creatorcontrib><creatorcontrib>Schaefer, Catherine</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hedström, Anna Karin</au><au>Lima Bomfim, Izaura</au><au>Barcellos, Lisa</au><au>Gianfrancesco, Milena</au><au>Schaefer, Catherine</au><au>Kockum, Ingrid</au><au>Olsson, Tomas</au><au>Alfredsson, Lars</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2014-03-11</date><risdate>2014</risdate><volume>82</volume><issue>10</issue><spage>865</spage><epage>872</epage><pages>865-872</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>OBJECTIVE:We investigated potential interactions between human leukocyte antigen (HLA) genotype and body mass index (BMI) status in relation to the risk of developing multiple sclerosis (MS). METHODS:We used 2 case-control studies, one with incident cases (1,510 cases, 2,017 controls) and one with prevalent cases (937 cases, 609 controls). Subjects with different genotypes and BMI were compared with regard to incidence of MS by calculating odds ratios (ORs) with 95% confidence intervals (CIs) employing logistic regression. Potential interactions between genotypes and BMI were evaluated by calculating the attributable proportion due to interaction. RESULTS:In both cohorts, a significant interaction was observed between HLA-DRB1*15 and obesity, regardless of HLA-A*02 status. Similarly, there was a significant interaction between absence of A*02 and obesity, regardless of DRB1*15 status. In the incident cohort, obese subjects with the most susceptible genotype (carriage of DRB1*15 and absence of A*02) had an OR of 16.2 (95% CI 7.5–35.2) compared to nonobese subjects without the genetic risk factors. The corresponding OR in the prevalent study was 13.8 (95% CI 4.1–46.8). CONCLUSIONS:We observed striking interactions between BMI status and HLA genotype with regard to MS risk. Hypothetically, a low-grade inflammatory response inherent to obesity synergizes with the adaptive, HLA molecule–restricted arm of the immune system, causing MS. Prevention of adolescent obesity may thus lower the risk of developing MS, predominantly among people with a genetic susceptibility to the disease.</abstract><cop>Hagerstown, MD</cop><pub>American Academy of Neurology</pub><pmid>24500647</pmid><doi>10.1212/WNL.0000000000000203</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2014-03, Vol.82 (10), p.865-872
issn 0028-3878
1526-632X
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_523800
source MEDLINE; Alma/SFX Local Collection; SWEPUB Freely available online; Journals@Ovid Complete
subjects Adolescent
Adult
Aged
Biological and medical sciences
Body Mass Index
Case-Control Studies
Female
Genetic Predisposition to Disease
Genotype
HLA-A2 Antigen - genetics
HLA-DRB1 Chains - genetics
Humans
Immunomodulators
Male
Medical sciences
Metabolic diseases
Middle Aged
Multiple Sclerosis - epidemiology
Multiple Sclerosis - etiology
Multiple Sclerosis - genetics
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Obesity
Pediatric Obesity - epidemiology
Pediatric Obesity - genetics
Pharmacology. Drug treatments
Risk Factors
Young Adult
title Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A05%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20adolescent%20obesity%20and%20HLA%20risk%20genes%20in%20the%20etiology%20of%20multiple%20sclerosis&rft.jtitle=Neurology&rft.au=Hedstr%C3%B6m,%20Anna%20Karin&rft.date=2014-03-11&rft.volume=82&rft.issue=10&rft.spage=865&rft.epage=872&rft.pages=865-872&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/WNL.0000000000000203&rft_dat=%3Cproquest_swepu%3E1635038235%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1635038235&rft_id=info:pmid/24500647&rfr_iscdi=true